These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21286080)

  • 41. Performance Goals for an Adjunct Diagnostic Test to Reduce Unnecessary Biopsies After Screening Mammography: Analysis of Costs, Benefits, and Consequences.
    Lee CI; Bensink ME; Berry K; Musa Z; Bodnar C; Dann R; Jarvik JG; Lehman CD; Ramsey SD
    J Am Coll Radiol; 2016 Nov; 13(11S):R81-R88. PubMed ID: 27814820
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of different mammographic radiation exposures on predicted benefits of screening for breast cancer.
    Dubin N
    Stat Med; 1982; 1(1):15-24. PubMed ID: 7187079
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biennial versus annual mammography and the risk of late-stage breast cancer.
    White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
    J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The control of breast cancer through mammography screening. What is the evidence?
    Tabár L; Dean PB
    Radiol Clin North Am; 1987 Sep; 25(5):993-1005. PubMed ID: 3306777
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Benefits versus risks from mammography: a critical reassessment.
    Mettler FA; Upton AC; Kelsey CA; Ashby RN; Rosenberg RD; Linver MN
    Cancer; 1996 Mar; 77(5):903-9. PubMed ID: 8608482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
    Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
    JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Screening for breast cancer with mammography.
    Gøtzsche PC; Nielsen M
    Cochrane Database Syst Rev; 2006 Oct; (4):CD001877. PubMed ID: 17054145
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Breast cancer mortality in organised mammography screening in Denmark: comparative study.
    Jørgensen KJ; Zahl PH; Gøtzsche PC
    BMJ; 2010 Mar; 340():c1241. PubMed ID: 20332505
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Digital versus screen-film mammography: impact of mammographic density and hormone therapy on breast cancer detection.
    Chiarelli AM; Prummel MV; Muradali D; Shumak RS; Majpruz V; Brown P; Jiang H; Done SJ; Yaffe MJ
    Breast Cancer Res Treat; 2015 Nov; 154(2):377-87. PubMed ID: 26518019
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk of radiation-induced breast cancer from mammographic screening.
    Yaffe MJ; Mainprize JG
    Radiology; 2011 Jan; 258(1):98-105. PubMed ID: 21081671
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mammography screening matters for young women with breast carcinoma: evidence of downstaging among 42-49-year-old women with a history of previous mammography screening.
    Buseman S; Mouchawar J; Calonge N; Byers T
    Cancer; 2003 Jan; 97(2):352-8. PubMed ID: 12518359
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detecting nonpalpable recurrent breast cancer: the role of routine mammographic screening of transverse rectus abdominis myocutaneous flap reconstructions.
    Lee JM; Georgian-Smith D; Gazelle GS; Halpern EF; Rafferty EA; Moore RH; Yeh ED; D'Alessandro HA; Hitt RA; Kopans DB
    Radiology; 2008 Aug; 248(2):398-405. PubMed ID: 18539887
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Screening for breast cancer with mammography.
    Gøtzsche PC; Nielsen M
    Cochrane Database Syst Rev; 2011 Jan; (1):CD001877. PubMed ID: 21249649
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: comparison of relative and absolute benefit.
    Kerlikowske K
    J Natl Cancer Inst Monogr; 1997; (22):79-86. PubMed ID: 9709281
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Informed decision making: age of 50 is arbitrary and has no demonstrated influence on breast cancer screening in women.
    Kopans DB
    AJR Am J Roentgenol; 2005 Jul; 185(1):177-82. PubMed ID: 16060005
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effectiveness of breast cancer screening by mammography in younger women.
    Elwood JM; Cox B; Richardson AK
    Online J Curr Clin Trials; 1993 Feb; Doc No 32():[23,227 words; 195 paragraphs]. PubMed ID: 8305999
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.
    Hendrick RE
    Radiology; 2018 May; 287(2):391-397. PubMed ID: 29267146
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The clinical significance of minimal breast cancer: a pathologist's viewpoint.
    Wirman JA
    Crit Rev Oncol Hematol; 1985; 3(1):35-74. PubMed ID: 2990747
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Population-based mammographic screening: does 'informed choice' require any less than full disclosure to individuals of benefits, harms, limitations and consequences?
    Ward J
    Aust N Z J Public Health; 1999 Jun; 23(3):301-4. PubMed ID: 10388176
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.